Related Experiment Video

Updated: Mar 20, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K

Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada

W Herring1, I Pearson2, M Purser1

  • 1RTI Health Solutions, Research Triangle Park, NC, USA.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|May 21, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.7K

Related Experiment Videos

Last Updated: Mar 20, 2026

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.7K

Related Concept Videos

Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
1.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K

Articles linked to this work by shared authors, journal, and citation graph.

Developing and evaluating definitions of real-world clinical endpoints for patients with early-stage triple-negative breast cancer using a United States of America secondary database.

ESMO real world data and digital oncology·2026

Rationale and recommendations for improving early-stage oncology diagnosis, treatment, and access.

Journal of medical economics·2026

The clinical and cost impact of switching to fingolimod versus other first line injectable disease-modifying therapies in patients with relapsing multiple sclerosis.

Current medical research and opinion·2019

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada.

Current oncology (Toronto, Ont.)·2016

Cost-effectiveness of pazopanib in advanced soft-tissue sarcoma in Canada.

Current oncology (Toronto, Ont.)·2014

Development and validation of a cost-utility model for Type 1 diabetes mellitus.

Diabetic medicine : a journal of the British Diabetic Association·2014

Cost-Effectiveness of Cilta-cel in Lenalidomide-Refractory Multiple Myeloma: An Analysis of the CARTITUDE-4 Trial.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Does conventional cost-effectiveness analysis disadvantage treatments for severe disease? Evidence from U.S. value assessments.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Incorporating Equity Considerations Related to Financial Protection Through Extended Cost-Effectiveness Analysis: A Systematic Review.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

How Long Should We Wait? The Impact of Immature Data on Colorectal Cancer Decision Modeling.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

What Age is Appropriate for Self-Reporting EQ-5D-Y-3L? Chinese Insights from a Sample of Children Aged 6-11 years.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026

Adverse events, quality of life, and work impairment in patients with chronic myeloid leukemia (CML)-a survey of first- and second-line tyrosine kinase inhibitor (TKI) intolerance in the US.

Leukemia & lymphoma·2026

Belatacept and the Risk of Cytomegalovirus, BK Polyomavirus, and Epstein-Barr Virus Post-transplant Lymphoproliferative Disease After Kidney Transplantation: A Meta-Analysis and Systematic Review.

Journal of transplantation·2026

Early Recognition of Neuroleptic Malignant Syndrome Without Hyperthermia: A Narrative Review.

Cureus·2026

The Great Mimicker: Variable Presentations of Xanthogranulomatous Salpingo-Oophoritis in a Case Series of Seven Patients From a Rural Tertiary Care Center.

Cureus·2026

Decision Fatigue and Associated Factors Among Patients with Hematologic Malignancies: Implications for Patient-Centered Decision Support.

Patient preference and adherence·2026

Oncocytic and Follicular Thyroid Carcinomas Arising in Hashimoto's Thyroiditis: Two Rare Cases Highlighting an Unusual Association.

Cureus·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us